Pembro and Vorinostat for Patients With Stage IV Non-small Cell Lung Cancer (NSCLC)

Clinical Trial ID NCT02638090

Rank	Title	Journal	Year	PubWeight™‹?›
1	Recent Advances in Immunotherapy in Metastatic NSCLC.	Front Oncol	2016	0.79